Exchange Traded Concepts, LLC Innate Pharma Sa Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Innate Pharma Sa stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 62,752 shares of IPHA stock, worth $139,309. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,752
Previous 77,350
18.87%
Holding current value
$139,309
Previous $142,000
21.83%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IPHA
# of Institutions
11Shares Held
127KCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY43.5KShares$96,6230.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il11.9KShares$26,3130.0% of portfolio
-
Gamma Investing LLC Foster City, CA3.98KShares$8,8240.01% of portfolio
-
Ubs Group Ag3.51KShares$7,7920.0% of portfolio
-
Rhumbline Advisers Boston, MA675Shares$1,4980.0% of portfolio
About Innate Pharma SA
- Ticker IPHA
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,893,000
- Market Cap $177M
- Description
- Innate Pharma S.A., a biotechnology company, discovers, develops, and commercializes therapeutic antibodies for the treatment of oncology indications in France and internationally. The company's products include Lacutamab (IPH4102), an anti-KIR3DL2 antibody, which is in Phase II clinical trials for the treatment of cutaneous T-cell and periphera...